Marina Perez-Gordo

Prof. Dr. Marina Perez-Gordo

CEU San Pablo University
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MPMariona Pascal
Mariona Pascal
Marina Perez-GordoMarina Perez-Gordo
Marina Perez-Gordo
TCTeresa Caballero
Teresa Caballero
Escribese M. M.Escribese M. M.
Escribese M. M.
MLM. Natividad Lopez Longo
M. Natividad Lopez Longo
CMCristobalina Mayorga
Cristobalina Mayorga
Allergic diseases, such as respiratory, cutaneous, and food allergy, have dramatically increased in prevalence over the last few decades. Recent research points to a central role of the microbiome, which is highly influenced by multiple environmental and dietary factors. It is well established that the microbiome can modulate the immune response, from cellular development to organ and tissue formation exerting its effects through multiple interactions with both the innate and acquired branches of the immune system. It has been described at some extent changes in environment and nutrition produce dysbiosis in the gut but also in the skin, and lung microbiome, inducing qualitative and quantitative changes in composition and metabolic activity. Here, we review the potential role of the skin, respiratory, and gastrointestinal tract (GIT) microbiomes in allergic diseases. In the GIT, the microbiome has been proven to be important in developing either effector or tolerant responses to different antigens by balancing the activities of Th1 and Th2 cells. In the lung, the microbiome may play a role in driving asthma endotype polarization, by adjusting the balance between Th2 and Th17 patterns. Bacterial dysbiosis is associated with chronic inflammatory disorders of the skin, such as atopic dermatitis and psoriasis. Thus, the microbiome can be considered a therapeutical target for treating inflammatory diseases, such as allergy. Despite some limitations, interventions with probiotics, prebiotics, and/or synbiotics seem promising for the development of a preventive therapy by restoring altered microbiome functionality, or as an adjuvant in specific immunotherapy.

5 September 2011 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
Marina Perez-GordoMarina Perez-Gordo
Marina Perez-Gordo
JLJing Lin
Jing Lin
LBLudmilla Bardina
Ludmilla Bardina
CVCarlos Pastor Vargas
Carlos Pastor Vargas
BCBarbara Cases
Barbara Cases
HSHugh A. Sampson
Hugh A. Sampson
Background: IgE epitope mapping of allergens reveals important information about antigen elicitors involved in allergic reactions. The peptide-based microarray immunoassay offers an advantage of scale and parallel design over previous methods of epitope mapping. It has been used to map epitopes of some food allergens but has never been used with fish allergens. Objective: We sought to develop a peptide microarray immunoassay to map allergenic fish epitopes of two isoforms of Atlantic salmon (Salmo salar) parvalbumin, Sal s 1 beta 1 and Sal s 1 beta 2. Methods: Sera from 16 fish-allergic patients with specific IgE to salmon parvalbumin were used. Twelve healthy volunteers were used as negative controls. A library of overlapping peptides was synthesized commercially, representing the primary sequence of Sal s 1 beta 1 and Sal s 1 beta 2. Peptides were used to analyze allergen-specific IgE antibodies by immunolabeling with patient sera. Results: Three antigenic regions, not previously described, were identified in Sal s 1 beta 1. Two of them correlated with those previously reported in Gad c 1, parvalbumin from Baltic cod (Gadus callarias). No allergenic regions were found in Sal s 1 beta 2. This could be explained by crucial amino acid substitutions between isoforms. Conclusions: We have identified three antigenic regions in Sal s 1 beta 1 using a peptide microarray immunoassay. These three sequential epitopes formed a unique antigenic determinant in the three-dimensional model of the protein. In addition, we proved that isoforms from the same protein might have a different allergenic behavior.

26 May 2007 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
THT. Hernández
T. Hernández
IEI. Estrella
I. Estrella
Marina Perez-GordoMarina Perez-Gordo
Marina Perez-Gordo
EAE. G. Alegría
E. G. Alegría
CTC. Tenorio
C. Tenorio
MMM.Victoria MORENO-ARRIBAS
M.Victoria MORENO-ARRIBAS

2 April 2013 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
Marina Perez-GordoMarina Perez-Gordo
Marina Perez-Gordo
CVCarlos Pastor Vargas
Carlos Pastor Vargas
JLJing Lin
Jing Lin
LBLudmilla Bardina
Ludmilla Bardina
BCBarbara Cases
Barbara Cases
HSHugh A. Sampson
Hugh A. Sampson

8 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
TTTomás Clive Barker Tejeda
Tomás Clive Barker Tejeda
Elisa Zubeldia-VarelaElisa Zubeldia-Varela
Elisa Zubeldia-Varela
AMAndrea Macías-Camero
Andrea Macías-Camero
LALola Alonso
Lola Alonso
IMIsabel Adoración Martín-Antoniano
Isabel Adoración Martín-Antoniano
ALMA VILLASEÑORALMA VILLASEÑOR
ALMA VILLASEÑOR
The human gut microbiome establishes and matures during infancy, and dysregulation at this stage may lead to pathologies later in life. We conducted a multi-omics study comprising three generations of family members to investigate the early development of the gut microbiota. Fecal samples from 200 individuals, including infants (0-12 months old; 55% females, 45% males) and their respective mothers and grandmothers, were analyzed using two independent metabolomics platforms and metagenomics. For metabolomics, gas chromatography and capillary electrophoresis coupled to mass spectrometry were applied. For metagenomics, both 16S rRNA gene and shotgun sequencing were performed. Here we show that infants greatly vary from their elders in fecal microbiota populations, function, and metabolome. Infants have a less diverse microbiota than adults and present differences in several metabolite classes, such as short- and branched-chain fatty acids, which are associated with shifts in bacterial populations. These findings provide innovative biochemical insights into the shaping of the gut microbiome within the same generational line that could be beneficial in improving childhood health outcomes.

1 February 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
DRDomenico Rosace
Domenico Rosace
CCCristina Gomez Casado
Cristina Gomez Casado
PFPaloma Fernandez
Paloma Fernandez
Marina Perez-GordoMarina Perez-Gordo
Marina Perez-Gordo
MDMaría del Carmen Dominguez
María del Carmen Dominguez
DBDomingo Barber
Domingo Barber